Yechezkel Barenholz

USPTO Granted Patents = 57 (Patent Applications = 18)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 12 (Patent Applications = 15)

Average Co-Inventor Count = 3.0

ph-index = 17

Forward Citations = 1,075(Granted Patents)

Forward Citations (Not Self Cited) = 1,028(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Jersusalem, IL (2001)
Jerusalem, IL (1989 - 2023)

Company Filing History:

42 out of 891

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Technion Research & Development Foundation Limited

patents

5. 2 out of 5

Hadassah Medical Organization

patents

6. 2 out of 15

Sequus Pharmaceuticals, Inc.

patents

7. 2 out of 169

Hadasit Medical Research Services and Development Ltd.

Hadasit Medical Research, Inc.

patent

11. 1 out of 1

Yissum Research and Development Company Et Al.

patent

12. 1 out of 4

Opperbas Holding B.v.

patents

13. 1 out of 559

Memorial Sloan Kettering Cancer Center

patents

14. 1 out of 1

University of Jerusalem Ltd.

patent

15. 1 out of 174

King's College London

patents

16. 1 out of 8

Shaare Zedek Scientific Ltd

patents

17. 1 out of 1

The Bay Zoltan Foundation for Applied Research

patent

18. 5 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2025

Loading Chart...

57 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12214077 - Liposomal formulation for joint lubrication (2025-02-04),

2. 11839685 - Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same (2023-12-12),

3. 11123293 - Liposomal formulation for joint lubrication (2021-09-21),

4. 10842745 - Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same (2020-11-24),

5. 10722599 - Lipid assemblies and uses thereof and some pH and electrostatic modulating lipids to be used in said assemblies (2020-07-28),

6. 10085940 - Liposomes co-encapsulating a bisphosphonate and an amphipathic agent (2018-10-02),

7. 10052387 - Ceramide reversal of multi-drug resistance (2018-08-21),

8. 10004688 - Liposomal mupirocin (2018-06-26),

9. 9713591 - Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same (2017-07-25),

10. 9078812 - Particulate drug carriers as desensitizing agents (2015-07-14),

11. 8932627 - Liposomal compositions of glucocorticoid and glucocorticoid derivatives (2015-01-13),

12. 8895054 - Methods for joint lubrication and cartilage wear prevention making use of glycerophospholipids (2014-11-25),

13. 8871276 - Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents (2014-10-28),

14. 8865223 - Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents (2014-10-21),

15. 8673285 - Sphingoid polyalkylamine conjugates for vaccination (2014-03-18),

Title: Yechezkel Barenholz - Innovator from Jerusalem

Introduction:

Yechezkel Barenholz is a renowned inventor hailing from Jerusalem, Israel. He has made significant contributions to the field of innovations and patents, particularly in the realm of pharmaceuticals and drug delivery systems.

Latest Patents:

Yechezkel Barenholz holds several patents related to liposome technology, a groundbreaking method for delivering drugs to specific targets in the body. His recent patents focus on enhancing the efficacy and safety of various medications through innovative delivery mechanisms.

Career Highlights:

Throughout his illustrious career, Yechezkel Barenholz has been at the forefront of pioneering research in liposomal drug delivery. His work has revolutionized the pharmaceutical industry, leading to the development of novel treatments for a wide range of medical conditions.

Collaborations:

Yechezkel Barenholz has collaborated with leading pharmaceutical companies, research institutions, and universities around the world to further advance the field of drug delivery systems. His partnerships have resulted in groundbreaking discoveries and innovative solutions that have benefited countless patients globally.

Conclusion:

In conclusion, Yechezkel Barenholz's dedication to innovation and his groundbreaking work in liposome technology have cemented his legacy as a visionary inventor in the field of pharmaceuticals. His contributions continue to have a profound impact on the healthcare industry, improving the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.